Target intelligence / Profile preview

Immunogenic Helicobacter pylori antigens (H. pylori antigens)

Target
H. pylori antigens
Molecular classification
Bacterial protein, Virulence factor, Antigen
01

Overview

Immunogenic Helicobacter pylori antigens are a diverse set of proteins produced by the bacterium Helicobacter pylori that elicit a host immune response and play pivotal roles in gastric pathogenesis [Cover and Blaser, 2009]. Key members of this group include Urease, which allows the bacteria to survive the acidic stomach environment, and major virulence factors such as Cytotoxin-associated gene A (CagA) and Vacuolating cytotoxin A (VacA) [Salama et al., 2013]. CagA is often referred to as a bacterial oncoprotein because it is injected into host cells, where it disrupts signaling pathways and promotes oncogenesis [Wroblewski et al., 2010]. VacA induces the formation of large vacuoles in gastric epithelial cells, leading to cell death and tissue damage [Cover and Blaser, 2009]. These antigens are the primary targets for the development of prophylactic and therapeutic vaccines, as well as the basis for non-invasive diagnostic tests like the stool antigen test and serology [Malfertheiner et al., 2022]. Despite their potential as therapeutic targets, the high genetic diversity of H. pylori strains and the risk of inducing autoimmune responses through molecular mimicry present significant challenges in drug and vaccine development [Salama et al., 2013; Chmiela and Gonciarz, 2017].

Other names
H. pylori virulence factorsHelicobacter pylori proteinsGastric bacterial antigens
02

Mechanism of action

Induction of neutralizing antibodies (IgA/IgG) and cellular immunity to block bacterial adhesion, neutralize toxins, and facilitate pathogen clearance.

03

Biological functions

Bacterial colonizationPathogenesisImmune evasionCell adhesionToxin productionAcid neutralization
04

Disease associations

GastritisPeptic ulcer diseaseGastric adenocarcinomaMALT lymphomaInfection
05

Safety considerations

Molecular mimicry with host Lewis blood group antigens leading to autoimmunityPotential for exacerbating gastric inflammationStrain-specific escape mutants reducing vaccine efficacy
06

Interacting drugs

Investigational H. pylori vaccines

2 more in the full profile.

07

Biomarkers

Anti-CagA IgG antibodyAnti-VacA IgG antibodyHelicobacter pylori stool antigenUrease activity (13C-Urea Breath Test)

Beyond the preview

Go deeper on Immunogenic Helicobacter pylori antigens (H. pylori antigens).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunogenic Helicobacter pylori antigens (H. pylori antigens).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call